Literature DB >> 23963994

CK2 kinase activity but not its binding to CK2 promoter regions is implicated in the regulation of CK2α and CK2β gene expressions.

Sarah Lupp1, Catalina Gumhold, Emmanuel Ampofo, Mathias Montenarh, Karen Rother.   

Abstract

Protein kinase CK2, a ubiquitous serine/threonine kinase in control of a variety of crucial cellular functions, is composed of catalytic α- and α'-subunits and non-catalytic β-subunits which form holoenzymes such as CK2(αβ)2, CK2αα'β2, or CK2(α'β)2. In addition, there is ample evidence for the occurrence of the individual subunits beside the holoenzyme. While the CK2 subunits are well analyzed on the protein level, only little is known about the regulation of their transcription. The existence of multiple forms of CK2 subunits raised the question about a mutual regulation of their expression. Here we defined two 5'-upstream regions of the CK2α and the CK2β genes, respectively, as sequences with promoter activities. We found that CK2α and CK2α' stimulated the expression of the reporter constructs whereas, CK2β was inactive. Using chromatin immunoprecipitation assays, we were unable to detect binding of endogenous CK2 subunits to these promoter sequences in vivo. However, it turned out that inhibition of the kinase activity of CK2 attenuated the promoter activity indicating that CK2α and CK2α' might regulate their gene expression indirectly by phosphorylation reactions. Thus, we have shown here (i) that under normal physiological conditions CK2 does not bind to CK2 promoter regions and (ii) that the CK2 kinase activity is implicated in the regulation of its own expression.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23963994     DOI: 10.1007/s11010-013-1782-8

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  61 in total

1.  B-MYB is required for recovery from the DNA damage-induced G2 checkpoint in p53 mutant cells.

Authors:  Mirijam Mannefeld; Elena Klassen; Stefan Gaubatz
Journal:  Cancer Res       Date:  2009-04-21       Impact factor: 12.701

2.  Casein kinase II. cDNA sequences, developmental expression, and tissue distribution of mRNAs for alpha, alpha', and beta subunits of the chicken enzyme.

Authors:  G Maridor; W Park; W Krek; E A Nigg
Journal:  J Biol Chem       Date:  1991-02-05       Impact factor: 5.157

3.  CK2α is essential for embryonic morphogenesis.

Authors:  Isabel Dominguez; Irene R Degano; Kathleen Chea; Julie Cha; Paul Toselli; David C Seldin
Journal:  Mol Cell Biochem       Date:  2011-07-15       Impact factor: 3.396

4.  Developmental and growth defects in mice with combined deficiency of CK2 catalytic genes.

Authors:  Esther Landesman-Bollag; Anna Belkina; Beth Hovey; Edward Connors; Charles Cox; David C Seldin
Journal:  Mol Cell Biochem       Date:  2011-07-19       Impact factor: 3.396

5.  Globozoospermia in mice lacking the casein kinase II alpha' catalytic subunit.

Authors:  X Xu; P A Toselli; L D Russell; D C Seldin
Journal:  Nat Genet       Date:  1999-09       Impact factor: 38.330

6.  Functional polymorphism of the CK2alpha intronless gene plays oncogenic roles in lung cancer.

Authors:  Ming-Szu Hung; Yu-Ching Lin; Jian-Hua Mao; Il-Jin Kim; Zhidong Xu; Cheng-Ta Yang; David M Jablons; Liang You
Journal:  PLoS One       Date:  2010-07-02       Impact factor: 3.240

7.  Structure of the gene encoding human casein kinase II subunit beta.

Authors:  H Voss; U Wirkner; R Jakobi; N A Hewitt; C Schwager; J Zimmermann; W Ansorge; W Pyerin
Journal:  J Biol Chem       Date:  1991-07-25       Impact factor: 5.157

8.  Human casein kinase II. The subunit alpha protein activates transcription of the subunit beta gene.

Authors:  A Robitzki; L Bodenbach; H Voss; W Pyerin
Journal:  J Biol Chem       Date:  1993-03-15       Impact factor: 5.157

9.  Structure of the gene encoding the murine protein kinase CK2 beta subunit.

Authors:  B Boldyreff; O G Issinger
Journal:  Genomics       Date:  1995-09-01       Impact factor: 5.736

10.  The interferon-gamma-mediated inhibition of lipoprotein lipase gene transcription in macrophages involves casein kinase 2- and phosphoinositide-3-kinase-mediated regulation of transcription factors Sp1 and Sp3.

Authors:  Sandra M Harris; Elizabeth J Harvey; Timothy R Hughes; Dipak P Ramji
Journal:  Cell Signal       Date:  2008-08-28       Impact factor: 4.315

View more
  7 in total

Review 1.  Protein kinase CK2 in breast cancer: the CK2β regulatory subunit takes center stage in epithelial plasticity.

Authors:  Odile Filhol; Sofia Giacosa; Yann Wallez; Claude Cochet
Journal:  Cell Mol Life Sci       Date:  2015-05-20       Impact factor: 9.261

2.  Activation of the PI3K/AKT pathway by microRNA-22 results in CLL B-cell proliferation.

Authors:  F Palacios; C Abreu; D Prieto; P Morande; S Ruiz; T Fernández-Calero; H Naya; G Libisch; C Robello; A I Landoni; R Gabus; G Dighiero; P Oppezzo
Journal:  Leukemia       Date:  2014-05-14       Impact factor: 11.528

3.  Tenfibgen-DMAT Nanocapsule Delivers CK2 Inhibitor DMAT to Prostate Cancer Xenograft Tumors Causing Inhibition of Cell Proliferation.

Authors:  Janeen H Trembley; Gretchen M Unger; Omar Cespedes Gomez; J Abedin; Vicci L Korman; Rachel I Vogel; Gloria Niehans; Betsy T Kren; Khalil Ahmed
Journal:  Mol Cell Pharmacol       Date:  2014

4.  Targeting casein kinase II restores Ikaros tumor suppressor activity and demonstrates therapeutic efficacy in high-risk leukemia.

Authors:  Chunhua Song; Chandrika Gowda; Xiaokang Pan; Yali Ding; Yongqing Tong; Bi-Hua Tan; Haijun Wang; Sunil Muthusami; Zheng Ge; Mansi Sachdev; Shantu G Amin; Dhimant Desai; Krishne Gowda; Raghavendra Gowda; Gavin P Robertson; Hilde Schjerven; Markus Muschen; Kimberly J Payne; Sinisa Dovat
Journal:  Blood       Date:  2015-07-28       Impact factor: 22.113

5.  CK2 Controls Th17 and Regulatory T Cell Differentiation Through Inhibition of FoxO1.

Authors:  Sara A Gibson; Wei Yang; Zhaoqi Yan; Hongwei Qin; Etty N Benveniste
Journal:  J Immunol       Date:  2018-06-11       Impact factor: 5.422

6.  Mining CK2 in cancer.

Authors:  Charina E Ortega; Yoshua Seidner; Isabel Dominguez
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

7.  Bistable Epigenetic States Explain Age-Dependent Decline in Mesenchymal Stem Cell Heterogeneity.

Authors:  Zahia Hamidouche; Karen Rother; Jens Przybilla; Axel Krinner; Denis Clay; Lydia Hopp; Claire Fabian; Alexandra Stolzing; Hans Binder; Pierre Charbord; Joerg Galle
Journal:  Stem Cells       Date:  2016-11-08       Impact factor: 6.277

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.